1. Home
  2. AFL vs COR Comparison

AFL vs COR Comparison

Compare AFL & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFL
  • COR
  • Stock Information
  • Founded
  • AFL 1955
  • COR 2001
  • Country
  • AFL United States
  • COR United States
  • Employees
  • AFL N/A
  • COR N/A
  • Industry
  • AFL Accident &Health Insurance
  • COR Other Pharmaceuticals
  • Sector
  • AFL Finance
  • COR Health Care
  • Exchange
  • AFL Nasdaq
  • COR Nasdaq
  • Market Cap
  • AFL 57.1B
  • COR 49.1B
  • IPO Year
  • AFL N/A
  • COR N/A
  • Fundamental
  • Price
  • AFL $104.08
  • COR $291.46
  • Analyst Decision
  • AFL Hold
  • COR Buy
  • Analyst Count
  • AFL 15
  • COR 10
  • Target Price
  • AFL $105.00
  • COR $305.90
  • AVG Volume (30 Days)
  • AFL 1.9M
  • COR 1.8M
  • Earning Date
  • AFL 04-30-2025
  • COR 07-30-2025
  • Dividend Yield
  • AFL 2.23%
  • COR 0.75%
  • EPS Growth
  • AFL N/A
  • COR N/A
  • EPS
  • AFL 6.44
  • COR 8.59
  • Revenue
  • AFL $16,889,000,000.00
  • COR $310,232,192,000.00
  • Revenue This Year
  • AFL N/A
  • COR $10.50
  • Revenue Next Year
  • AFL $1.79
  • COR $6.77
  • P/E Ratio
  • AFL $16.15
  • COR $33.95
  • Revenue Growth
  • AFL N/A
  • COR 12.19
  • 52 Week Low
  • AFL $86.46
  • COR $218.65
  • 52 Week High
  • AFL $115.50
  • COR $309.35
  • Technical
  • Relative Strength Index (RSI)
  • AFL 46.91
  • COR 55.06
  • Support Level
  • AFL $101.88
  • COR $285.98
  • Resistance Level
  • AFL $104.01
  • COR $295.25
  • Average True Range (ATR)
  • AFL 1.62
  • COR 4.75
  • MACD
  • AFL -0.01
  • COR -0.23
  • Stochastic Oscillator
  • AFL 42.36
  • COR 70.52

About AFL AFLAC Incorporated

Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.

About COR Cencora Inc.

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Share on Social Networks: